1. Home
  2. CPIX vs GLV Comparison

CPIX vs GLV Comparison

Compare CPIX & GLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$5.64

Market Cap

73.6M

Sector

Health Care

ML Signal

HOLD

Logo Clough Global Dividend and Income Fund of beneficial interest

GLV

Clough Global Dividend and Income Fund of beneficial interest

HOLD

Current Price

$6.38

Market Cap

77.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPIX
GLV
Founded
1999
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
73.6M
77.2M
IPO Year
2007
2004

Fundamental Metrics

Financial Performance
Metric
CPIX
GLV
Price
$5.64
$6.38
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
116.6K
51.6K
Earning Date
05-05-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
58.70
N/A
EPS
N/A
N/A
Revenue
$42,010,949.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.75
N/A
52 Week Low
$1.85
$5.50
52 Week High
$6.61
$6.49

Technical Indicators

Market Signals
Indicator
CPIX
GLV
Relative Strength Index (RSI) 56.15 56.46
Support Level $5.40 $5.83
Resistance Level $6.04 $6.49
Average True Range (ATR) 0.40 0.10
MACD -0.10 -0.01
Stochastic Oscillator 16.94 53.25

Price Performance

Historical Comparison
CPIX
GLV

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About GLV Clough Global Dividend and Income Fund of beneficial interest

Clough Global Dividend and Income Fund is a closed-ended investment management company. The fund's investment objective is to provide a high level of total return. It invests in equity and debt securities in both U.S. and non-U.S. markets of companies of any market capitalization.

Share on Social Networks: